SCYNEXIS (SCYX) Earnings Date & Reports

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

SCYX is expected to report earnings to fall 79.37% to -69 cents per share on August 17

Q2'26

Est.

$-0.69

Q1'26

Missed

by $2.32

Q4'25

Beat

by $0.12

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.06

The last earnings report on May 11 showed earnings per share of -335 cents, missing the estimate of -103 cents. With 62.10K shares outstanding, the current market capitalization sits at 40.42M.

View a ticker or compare two or three

Compare

SCYX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for SCYX